6 things longevity research actually agrees on
Strip out the noise and the field is narrower, duller and more useful than it looks.

Longevity research attracts a great deal of nonsense. Underneath it sits a fairly small set of findings that nearly everyone in the field accepts. Here are six.
It is a mitochondrial story before anything else
Cellular energy production sits upstream of almost every marker researchers track.
Declining output explains far more of the midlife experience than any single hormone does.

NAD+ availability falls measurably with age
This coenzyme participates in hundreds of metabolic reactions and in routine DNA repair.
Its decline is one of the most consistently replicated findings in the literature.
Aerobic capacity is the strongest single predictor
Across large datasets, measured cardiorespiratory fitness outperforms nearly every other variable studied.
No compound in any catalogue competes with it, and the research does not claim otherwise.

Lean mass loss is a mortality variable, not a vanity one
Muscle loss from midlife onward is associated with function, independence and resilience in later decades.
Resistance training is the only reliable intervention against it.
Mitochondrial peptides are a genuinely new research direction
MOTS-c originates inside the mitochondria and is studied for its role in metabolic regulation signalling.
That a mitochondrion produces its own signalling peptide was itself a recent finding.
Mechanism is well described, long-term outcomes are not
This is the honest state of the field, and any source that says otherwise is selling something.
Epithalon research on telomere biology is a clear example: interesting mechanism, limited long-term human data.
The useful version of longevity research is unglamorous and mostly about keeping cellular energy production intact. Biogenesis Labs publishes certificates of analysis across its catalogue and supplies every compound strictly for laboratory research use.